List of insiders holdings for BICYCLE THERAPEUTICS PLC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
2025-01-06 18:12:24 | 0 10,017,276 |
10,017,276 | Form 4 |
| 2 | HARLAND DEBORAH Director |
2019-05-30 21:25:55 | 0 1,915,275 |
1,915,275 | Form 4 |
| 3 | Cambridge Innovation Capital (Jersey) Ltd 10% Owner |
2019-06-07 16:31:22 | 1,751,437 0 |
1,751,437 | Form 13D |
| 4 | Anstey Michael Director |
2019-05-30 21:26:25 | 0 1,751,437 |
1,751,437 | Form 4 |
| 5 | SVLSF V LLC SV LIFE SCIENCES FUND V LP SV Life Sciences Fund V (GP) LP SV Life Sciences Fund V Strategic Partners L.P. 10% Owner |
2021-08-16 11:19:29 | 1,562,451 0 |
1,562,451 | Form 13D |
| 6 | GLAXOSMITHKLINE PLC 10% Owner |
2023-07-19 18:29:21 | 1,529,561 0 |
1,529,561 | Form 13D |
| 7 | NG CAROLYN Director |
2019-05-31 06:05:48 | 0 1,427,151 |
1,427,151 | Form 4/A |
| 8 | TYBOURNE CAPITAL MANAGEMENT (HK) LTD Tybourne Capital Management Ltd Tybourne Kesari Ltd Krishnan Viswanathan AQUILA INVESTMENTS IV 10% Owner |
2022-03-14 09:29:20 | 1,408,259 0 |
1,408,259 | Form 13D |
| 9 | Vertex Global Healthcare Fund I Pte Ltd. 10% Owner |
2021-01-20 16:30:17 | 883,475 0 |
883,475 | Form 13D |
| 10 | Novartis Bioventures Ltd NOVARTIS AG 10% Owner |
2022-02-11 16:32:19 | 673,360 0 |
673,360 | Form 13G |
| 11 | Lee Kevin CHIEF EXECUTIVE OFFICER |
2025-04-04 17:35:09 | 486,265 0 |
486,265 | Form 4 |
| 12 | Winter Gregory Paul Director |
2025-01-06 19:30:16 | 199,427 0 |
199,427 | Form 4 |
| 13 | Arroyo Santiago CHIEF DEVELOPMENT OFFICER |
2025-01-06 19:30:29 | 156,057 0 |
156,057 | Form 4 |
| 14 | Skynner Michael CHIEF TECHNOLOGY OFFICER |
2025-04-04 17:35:11 | 121,870 0 |
121,870 | Form 4 |
| 15 | Milnes Alistair CHIEF OPERATING OFFICER |
2025-04-04 17:35:08 | 97,617 0 |
97,617 | Form 4 |
| 16 | Crockett Nigel CHIEF BUSINESS OFFICER |
2025-01-06 19:30:27 | 72,803 0 |
72,803 | Form 4 |
| 17 | Smethurst Dominic Chief Medical Officer |
2023-01-05 21:18:03 | 71,699 0 |
71,699 | Form 4 |
| 18 | Legault Pierre Director |
2025-01-06 19:30:33 | 71,000 0 |
71,000 | Form 4 |
| 19 | Keen Nicholas CHIEF SCIENTIFIC OFFICER |
2024-07-08 18:55:08 | 62,024 7,000 |
69,024 | Form 4 |
| 20 | Westin Eric Chief Medical Officer |
2025-03-27 17:15:50 | 58,000 0 |
58,000 | Form 4 |
| 21 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF |
2025-04-04 17:35:06 | 54,547 0 |
54,547 | Form 4 |
| 22 | Young Alethia Chief Financial Officer |
2025-04-04 17:35:13 | 45,390 0 |
45,390 | Form 4 |
| 23 | Leone Peter Brian Chief Business Officer |
2019-05-30 21:25:10 | 43,269 0 |
43,269 | Form 4 |
| 24 | BINGHAM KATE Director |
2021-07-20 16:17:27 | 0 38,708 |
38,708 | Form 4/A |
| 25 | Riva Alessandro Director |
2025-03-27 17:17:20 | 37,500 0 |
37,500 | Form 4 |
| 26 | Kender Richard N Director |
2025-01-06 19:30:10 | 35,500 0 |
35,500 | Form 4 |
| 27 | Gutierrez-Ramos Jose-Carlos Director |
2025-01-06 19:30:07 | 35,500 0 |
35,500 | Form 4 |
| 28 | Bourque Janice Director |
2025-01-06 19:30:05 | 35,500 0 |
35,500 | Form 4 |
| 29 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER |
2025-04-04 17:35:04 | 31,827 0 |
31,827 | Form 4 |
| 30 | Kalowski Lee President and CFO |
2023-04-05 16:41:25 | 30,309 0 |
30,309 | Form 4 |
| 31 | Jordan Veronica GH Director |
2024-01-04 18:31:58 | 28,750 0 |
28,750 | Form 4 |
| 32 | Sands Stephen H. Director |
2025-01-06 19:30:14 | 28,180 0 |
28,180 | Form 4 |
| 33 | Hau Bosun Director |
2019-06-03 16:05:56 | 0 0 |
0 | Form 3/A |